Order Article Reprints

Law JW, Mitra D, Kaplan HG, Alfred T, Brufsky AM, Emir B, McCracken H, Liu X, Broome RG, Zhang C, et al. Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US Syapse Learning Health Network. Current Oncology. 2022; 29(2):1047-1061. https://doi.org/10.3390/curroncol29020089

Law, Jeanna Wallenta, Debanjali Mitra, Henry G. Kaplan, Tamuno Alfred, Adam M. Brufsky, Birol Emir, Haley McCracken, Xianchen Liu, Ronda G. Broome, Chenan Zhang, and et al. 2022. "Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US Syapse Learning Health Network" Current Oncology 29, no. 2: 1047-1061. https://doi.org/10.3390/curroncol29020089

Law, J. W., Mitra, D., Kaplan, H. G., Alfred, T., Brufsky, A. M., Emir, B., McCracken, H., Liu, X., Broome, R. G., Zhang, C., DiCristo, C., & Chen, C. (2022). Real-World Treatment Patterns and Clinical Effectiveness of Palbociclib Plus an Aromatase Inhibitor as First-Line Therapy in Advanced/Metastatic Breast Cancer: Analysis from the US Syapse Learning Health Network. Current Oncology, 29(2), 1047-1061. https://doi.org/10.3390/curroncol29020089